MedTrace Logo

Calcium Electroporation for Treatment of Cutaneous Metastases

NCT01941901 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2019-11-05

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of calcium electroporation on cutaneous metastases, and compare calcium electroporation with standard treatment: electrochemotherapy.

Conditions

  • Cutaneous Metastases

Interventions

DRUG

Calcium electroporation

Intratumoral injection, once only treatment.

DRUG

Electrochemotherapy with bleomycin

Intratumoral injection, once only treatment

Sponsors & Collaborators

  • Herlev Hospital

    lead OTHER

Principal Investigators

  • Julie Gehl · Department of Oncology, Copenhagen University hospital, Herlev

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2016-09-30
Completion
2017-01-23

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01941901 on ClinicalTrials.gov